Home/Filings/4/0001628280-22-025265
4//SEC Filing

White Lale 4

Accession 0001628280-22-025265

CIK 0001213037other

Filed

Sep 19, 8:00 PM ET

Accepted

Sep 20, 6:08 PM ET

Size

5.2 KB

Accession

0001628280-22-025265

Insider Transaction Report

Form 4
Period: 2022-09-19
White Lale
Director
Transactions
  • Purchase

    Common Stock

    2022-09-19$1.64/sh+15,000$24,525113,788 total(indirect: By Trust)
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.625 to $1.64. Full information regarding the number of shares purcahsed at each separate price can be furnished to the SEC staff upon request.

Issuer

Cardiff Oncology, Inc.

CIK 0001213037

Entity typeother

Related Parties

1
  • filerCIK 0001635493

Filing Metadata

Form type
4
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 6:08 PM ET
Size
5.2 KB